Assisted Reproductive Technology Market Dynamics: A Fertility Revolution Unveiled

The Business Research Company has updated its global market reports with latest data for 2024 and projections up to 2033

LONDON, GREATER LONDON, UK, January 2, 2024 /EINPresswire.com/ — The assisted reproductive technology (ART) market has experienced a significant surge, escalating from $38.04 billion in 2023 to a projected $45.42 billion in 2024, boasting an impressive Compound Annual Growth Rate (CAGR) of 19.4%. This upward trajectory is poised to continue, with an anticipated market size of $91.8 billion by 2028, maintaining a robust CAGR of 19.2%.

Rising Infertility Cases: A Market Catalyst:
The prevalence of infertility cases worldwide is expected to be a primary driver of the assisted reproductive technology market in the forthcoming years. Infertility, defined as the inability to conceive after a year of frequent and unprotected intercourse, affects a substantial proportion of the global population. According to the World Health Organization (WHO), an estimated 1 in 6 adults, or approximately 17.5% of the global adult population, grapple with infertility. The global struggle with infertility is anticipated to fuel the demand for ART, which encompasses fertility therapies working with both male and female reproductive elements. This underscores the pivotal role of ART in addressing infertility challenges on a global scale.

Explore the Global Assisted Reproductive Technology Market with a Detailed Sample Report:

Obesity’s Impact on Fertility Drives Demand:
The escalating prevalence of obesity emerges as a significant factor propelling the growth of the assisted reproductive technology market. Obesity, characterized by an excessive accumulation of body fat with adverse effects on health, is linked to irregular menstrual cycles, ovulatory dysfunction, and reduced sperm quality—factors that increase the likelihood of infertility. As obesity awareness grows, individuals and couples are seeking specialized ART services, contributing to a surge in market demand. The World Heart Federation reports that globally, around 2.3 billion adults and children were obese or overweight in March 2023, with projections indicating an increase to 2.7 billion by 2025. The increasing prevalence of obesity is, therefore, a driving force behind the growth of the assisted reproductive technology market.

Key Market Players Shaping the Landscape:
Major companies at the forefront of the assisted reproductive technology market include Cooper Surgical Inc., Ferring Pharmaceuticals Ltd., Hamilton Thorne Ltd., Merck KGaA, Genea Limited, California Cryobank, European Sperm Bank, OvaScience Inc., Vitrolife AB, and many more. These industry leaders play a pivotal role in developing and offering advanced ART solutions, contributing to the market’s evolution.

Technological Advancements Redefining ART:
Technological advancements stand out as a key trend shaping the assisted reproductive technology market. Companies are actively engaged in developing innovative technological solutions to strengthen their market position. For example, Alife Health launched the Alife Assist platform, leveraging data-driven insights and artificial intelligence (AI) to revolutionize the in-vitro fertilization (IVF) process. This platform, encompassing Stim Assist, Embryo Assist, and Insights, aids clinical decision-making, enhances real-time performance monitoring, and ultimately improves success rates in IVF procedures.

Innovative Products Expanding PGT-A Alternatives:
Leading companies are introducing innovative products to gain a competitive edge. Thermo Fisher Scientific Inc., for instance, launched two new next-generation sequencing-based options supporting preimplantation genetic testing-aneuploidy (PGT-A). These products, the Ion ReproSeq PGT-A Kit and the Ion AmpliSeq Polyploidy Kit, are designed to enhance aneuploidy analysis in reproductive health labs, offering complete workflows from sample to result and providing valuable insights to increase the success rate of future pregnancies.

Regional Dynamics: Europe Takes the Lead:
In 2023, Europe emerged as the largest region in the assisted reproductive technology market, with North America following closely. Comprehensive market coverage extends across Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Market Segmentation:
The assisted reproductive technology market covered in this report is segmented –
1) By Diagnosis: Ovulation Testing, Hysterosalpingography, Ovarian Reserve Testing, Genetic Testing
2) By Procedure Type: Fresh Non-Donor, Fresh Donor, Frozen Donor, Frozen Non-Donor, Embryo Or Egg Banking
3) By End-User: Hospitals, Fertility Clinics, Other End-Users

Access the Complete Report for In-Depth Analysis:

Assisted Reproductive Technology Global Market Report 2023 from TBRC covers the following information:
• Market size date for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.

The Assisted Reproductive Technology Global Market Report 2023 by The Business Research Company is the most comprehensive report that provides insights on assisted reproductive technology market size, assisted reproductive technology market drivers and trends, assisted reproductive technology market major players, assisted reproductive technology market competitors’ revenues, assisted reproductive technology market positioning, and assisted reproductive technology market growth across geographies. The assisted reproductive technology market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:
Fertility Services Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/fertility-services-global-market-report
Fertility Treatments Global Market Report 2023
https://www.thebusinessresearchcompany.com/report/fertility-treatments-global-market-report
Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Report 2023

About The Business Research Company
The Business Research Company has published over 3000+ detailed industry reports, spanning over 6500+ market segments and 60 geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: [email protected]

Check out our:
LinkedIn:
Twitter:
Facebook:
YouTube:
Blog:
Healthcare Blog:
Global Market Model:

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
Facebook
Twitter
LinkedIn

(4) Battling Anemia: Chemotherapy-Induced Anemia Market Insights, Growth Drivers, and Innovations! 💉💪 – YouTube